BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24401216)

  • 1. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.
    Barbour JD; Jalbert EC; Chow DC; Gangcuangco LM; Norris PJ; Keating SM; Heitman J; Nagamine L; Seto T; Ndhlovu LC; Nakamoto BK; Hodis HN; Parikh NI; Shikuma CM
    Atherosclerosis; 2014 Jan; 232(1):52-8. PubMed ID: 24401216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.
    Chow DC; Kagihara JM; Zhang G; Souza SA; Hodis HN; Li Y; Mitchell BI; Nakamoto BK; Kallianpur KJ; Keating SM; Norris PJ; Kohorn LB; Ndhlovu LC; Shikuma CM
    HIV Clin Trials; 2016 May; 17(3):114-22. PubMed ID: 27125366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma CD16
    Marques de Menezes EG; Deng X; Liu J; Bowler SA; Shikuma CM; Stone M; Hunt PW; Ndhlovu LC; Norris PJ
    mBio; 2022 Jun; 13(3):e0300521. PubMed ID: 35435733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
    Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
    Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study.
    Hileman CO; Carman TL; Longenecker CT; Labbato DE; Storer NJ; White CA; McComsey GA
    Antivir Ther; 2013; 18(7):921-9. PubMed ID: 23756436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.
    Dirajlal-Fargo S; Sattar A; Kulkarni M; Funderburg N; McComsey GA
    HIV Clin Trials; 2017 Jul; 18(4):156-163. PubMed ID: 28828963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Circulating Inflammatory Monocytes and Cardiovascular Disease Measures of Carotid Intimal Thickness.
    SahBandar IN; Ndhlovu LC; Saiki K; Kohorn LB; Peterson MM; D'Antoni ML; Shiramizu B; Shikuma CM; Chow DC
    J Atheroscler Thromb; 2020 May; 27(5):441-448. PubMed ID: 31588100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.
    Ross AC; Rizk N; O'Riordan MA; Dogra V; El-Bejjani D; Storer N; Harrill D; Tungsiripat M; Adell J; McComsey GA
    Clin Infect Dis; 2009 Oct; 49(7):1119-27. PubMed ID: 19712036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
    Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low CD4 Cell Counts Are Associated with Carotid Plaque and Intima-Media Thickness in Virologically Suppressed HIV-Infected Asians Older Than 50 Years.
    Siwamogsatham S; Chutinet A; Vongsayan P; Samajarn J; Putcharoen O; Aponpong T; Hiransuthikul A; Gatechompol S; Han WM; Chattranukulchai P; Kerr SJ; Ruxrungtham K; Avihingsanon A;
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1160-1169. PubMed ID: 31530175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma tissue factor and immune activation are associated with carotid intima-media thickness progression in treated HIV infection.
    Hsu DC; Ma YF; Narwan A; Rahalkar S; Rupert A; Scherzer R; Mills C; Deeks S; Sereti I; Hsue PY
    AIDS; 2020 Mar; 34(4):519-528. PubMed ID: 31634197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort.
    Baker JV; Henry WK; Patel P; Bush TJ; Conley LJ; Mack WJ; Overton ET; Budoff M; Hammer J; Carpenter CC; Hodis HN; Brooks JT;
    Clin Infect Dis; 2011 Oct; 53(8):826-35. PubMed ID: 21860012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between the Framingham Risk Score and Carotid Artery Intima-Media Thickness in Patients With Human Immunodeficiency Virus.
    Sumayin Ngamdu K; Adewale OO; Mallawaarachchi I; Alozie OK; Dwivedi AK; Bhatt DL
    Am J Cardiol; 2020 Jul; 127():156-162. PubMed ID: 32466846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating CD14+ and CD14
    Ammirati E; Moroni F; Magnoni M; Di Terlizzi S; Villa C; Sizzano F; Palini A; Garlaschelli K; Tripiciano F; Scotti I; Catapano AL; Manfredi AA; Norata GD; Camici PG
    Atherosclerosis; 2016 Dec; 255():171-178. PubMed ID: 27751505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study.
    Jung M; Parrinello CM; Xue X; Mack WJ; Anastos K; Lazar JM; Selzer RH; Shircore AM; Plankey M; Tien P; Cohen M; Gange SJ; Hodis HN; Kaplan RC
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25699995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.
    Rajasuriar R; Kong YY; Nadarajah R; Abdullah NK; Spelman T; Yuhana MY; Ponampalavanar S; Kamarulzaman A; Lewin SR
    J Transl Med; 2015 Jan; 13():30. PubMed ID: 25622527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
    Butterfield TR; Hanna DB; Kaplan RC; Kizer JR; Durkin HG; Young MA; Nowicki MJ; Tien PC; Golub ET; Floris-Moore MA; Titanji K; Fischl MA; Heath SL; Martinson J; Crowe SM; Palmer CS; Landay AL; Anzinger JJ
    AIDS; 2017 Jan; 31(2):199-205. PubMed ID: 27835618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection.
    Stein JH; Brown TT; Ribaudo HJ; Chen Y; Yan M; Lauer-Brodell E; McComsey GA; Dubé MP; Murphy RL; Hodis HN; Currier JS
    AIDS; 2013 Mar; 27(6):929-937. PubMed ID: 23196938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.